Role of urotensin II and its receptor in health and disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Anesthesia

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00540-007-0524-zPMID 17680191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.

  2007influential reference
• Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide.

  2006influential reference
• The role of urotensin II in cardiovascular and renal physiology and diseases

  2006cited by this paper
• Urotensin-II levels in acute coronary syndromes.

  2006cited by this paper
• Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients

  2006cited by this paper
• In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP‐803)

  2006cited by this paper
• Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.

  2006cited by this paper
• Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity

  2006influential reference
• The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

  2006cited by this paper
• Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.

  2006cited by this paper
• The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats

  2006cited by this paper
• Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.

  2006cited by this paper
• Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance.

  2006cited by this paper
• Localization of the urotensin II receptor in the rat central nervous system

  2006cited by this paper
• Nitric oxide and the vascular endothelium.

  2006cited by this paper
• Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation

  2006cited by this paper
• Urotensin-II receptor antagonists.

  2006cited by this paper
• Urotensin II is raised in children with congenital heart disease

  2005influential reference
• Increased plasma levels of Urotensin-II in preeclampsia-eclampsia: a new mediator in pathogenesis?

  2005cited by this paper
• Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.

  2005cited by this paper
• Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.

  2005cited by this paper
• Urotensin II: Its Function in Health and Its Role in Disease

  2005cited by this paper
• Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study.

  2005cited by this paper
• Nonpeptidic urotensin‐II receptor antagonists I: in vitro pharmacological characterization of SB‐706375

  2005cited by this paper
• Urotensin II in patients with chronic heart failure

  2005cited by this paper
• Urotensin II: the old kid in town.

  2004cited by this paper
• Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain.

  2004cited by this paper
• [Clinical study of plasma urotensin II in patients with coronary heart disease].

  2004cited by this paper
• Urotensin-II levels in children with minimal change nephrotic syndrome

  2004influential reference
• Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.

  2004cited by this paper
• Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

  2004cited by this paper
• Urotensin II, a novel peptide in central and peripheral cardiovascular control.

  2004cited by this paper
• Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese.

  2004cited by this paper
• Differential levels of "urotensin-II-like" activity determined by radio-receptor and radioimmuno-assays.

  2004cited by this paper
• Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines

  2004cited by this paper
• Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

  2004cited by this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cited by this paper
• Plasma concentration of urotensin II is raised in hypertension

  2004cited by this paper
• The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.

  2004cited by this paper
• Differential Effect of Urotensin II on Vascular Tone in Normal Subjects and Patients With Chronic Heart Failure

  2004cited by this paper
• Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.

  2004cited by this paper
• Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy.

  2004cited by this paper
• Central cardiovascular action of urotensin II in conscious rats

  2003cited by this paper
• Increased plasma urotensin II levels in patients with diabetes mellitus.

  2003cited by this paper
• Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions

  2003cited by this paper
• Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.

  2003cited by this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

  2003cited by this paper
• Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

  2003influential reference
• A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study

  2003cited by this paper
• Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

  2003cited by this paper
• Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure.

  2003cited by this paper
• [Clinical study of changes of urotensin II in patients with congestive heart failure].

  2003cited by this paper
• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.

  2002cited by this paper
• Is urotensin‐II the new endothelin?

  2002cited by this paper
• Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

  2002cited by this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002influential reference
• A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.

  2002cited by this paper
• Congestive heart failure and expression of myocardial urotensin II.

  2002cited by this paper
• No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.

  2002cited by this paper
• Plasma urotensin II in heart failure.

  2002influential reference
• UROTENSIN II MEDIATES ERK1/2 PHOSPHORYLATION AND PROLIFERATION IN GPR14-TRANSFECTED CELL LINES

  2002cited by this paper
• Urotensin‐II regulates intracellular calcium in dissociated rat spinal cord neurons

  2002cited by this paper
• Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

  2002cited by this paper
• Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

  2002cited by this paper
• High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.

  2002cited by this paper
• A new ligand for the urotensin II receptor

  2002cited by this paper
• Cardiostimulant effects of urotensin‐II in human heart in vitro

  2001cited by this paper
• Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

  2001cited by this paper
• Role of urotensin II in patients on dialysis.

  2001cited by this paper
• Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat.

  2001cited by this paper
• Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

  2001cited by this paper
• Depressor and regionally‐selective vasodilator effects of human and rat urotensin II in conscious rats

  2001cited by this paper
• Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.

  2001influential reference
• Human urotensin II increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition.

  2001cited by this paper
• Urotensin II: fish neuropeptide catches orphan receptor.

  2000cited by this paper
• Human urotensin II mediates vasoconstriction via an increase in inositol phosphates.

  2000cited by this paper
• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000cited by this paper
• Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1

  2000cited by this paper
• Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteries

  2000influential reference
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper
• Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

  2000cited by this paper
• Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists.

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Cellular mechanisms of cardiac hypertrophy

  1998cited by this paper
• Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.

  1991cited by this paper
• Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.

  1991cited by this paper
• Functional receptors for fish neuropeptide urotensin II in major rat arteries.

  1988cited by this paper
• The influence of urotensin II on calcium flux in rat aorta

  1988cited by this paper
• Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.

  1985cited by this paper
• Pharmacological Analysis of Urotensin-induced Contraction and Relaxation in Isolated Rabbit Aortas

  1979cited by this paper

• Role of Urotensin II in Intrauterine Atherosclerosis in Rabbits

  2025cites this paper
• Structural insights into hormone recognition and G-protein coupling of the urotensin-II receptor

  2025cites this paper
• The effects of the urotensin-II receptor antagonist palosuran treatment on the corpora cavernosa of streptozotocin-induced diabetic rats

  2024cites this paper
• Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics.

  2023cites this paper
• Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea

  2023cites this paper
• Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis

  2022cites this paper
• Is urotensin 2 levels related to disease progression in acromegaly

  2021cites this paper
• An Investigation of Saliva and Plasma Levels of Urotensin-2 in Recently Diagnosed Type 2 Diabetes Mellitus Patients on Metformin Treatment.

  2020cites this paper
• Birth Weight Standard Deviation Score is a Significant Determinant of Serum Urotensin-II Levels at Term-Equivalent Age in Preterm Infants

  2020cites this paper
• Identification and signaling characterization of four urotensin II receptor subtypes in the western clawed frog, Xenopus tropicalis.

  2020cites this paper
• Urotensin 2 and Oxidative Stress Levels in Maternal Serum in Pregnancies Complicated by Intrauterine Growth Restriction

  2019cites this paper
• Novel insights into the role of urotensin II in cardiovascular disease.

  2019cites this paper
• Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

  2019cites this paper
• Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels

  2019cites this paper
• Plasma urotensin-2 as a marker for menstrual irregularities in women: a clinical study

  2019cites this paper
• The role of urotensin‐II and its receptors in sepsis‐induced lung injury under diabetic conditions

  2018cites this paper
• Synthèse en phase solide de pyrrolo[3,2-e][1,4]diazépin-2-ones modulateurs du système urotensinergétique

  2017cites this paper
• Urantide protects CCl4-induced liver injury via inhibiting GPR14 signal in mice

  2017influential citation
• serum Evaluation of serum urotensin-II levels of children with ADHD and autism spectrum disorder

  2017cites this paper
• Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics.

  2017cites this paper
• UII/GPR14 is involved in NF-κB-mediated colonic inflammation in vivo and in vitro.

  2016cites this paper
• Relationship between polymorphism Ser 89 Asn of UTS 2 gene and atherosclerotic cerebral infarction in Chinese Hunan Han population

  2016cites this paper
• Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer

  2015cites this paper
• De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one γ-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex Vivo.

  2015cites this paper
• EDITORIAL SERIES ON METHODOLOGY 5 Radioimmunoassay, enzyme and non-enzyme-based immunoassays

  2014cites this paper
• New molecule in the etiology of schizophrenia: Urotensin II

  2014cites this paper
• Lack of Association of Urotensin II Gene Polymorphism with Atherosclerotic Cerebral Infarction Risk in the Southern Han Population Research

  2014cites this paper
• The Importence of Urotensin and Urotensin Receptors in Cardiovascular System

  2014cites this paper
• Radioimmunoassay, enzyme and non-enzyme-based immunoassays.

  2014cites this paper
• Urantide improves atherosclerosis by controlling C-reactive protein, monocyte chemotactic protein-1 and transforming growth factor-β expression in rats

  2014cites this paper
• Edinburgh Research Explorer Endothelium-derived endothelin-1

  2013cites this paper
• Measurement of [Ca²⁺]i in whole cell suspensions using Fura-2.

  2013cites this paper
• Urotensin II in Invertebrates: From Structure to Function in Aplysia californica

  2012cites this paper
• Urotensin II levels in patients with chronic kidney disease and kidney transplants

  2012influential citation
• In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands

  2012cites this paper
• A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects

  2010cites this paper
• Raised Plasma Urotensin II in Type 2 Diabetes Patients Is Associated With the Metabolic Syndrome Phenotype

  2010cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.

  2010cites this paper
• Endothelium-derived endothelin-1

  2010cites this paper
• Meta-Analysis of Genome-Wide Gene Expression Differences in Onset and Maintenance Phases of Genetic Hypertension

  2010cites this paper
• Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

  2009cites this paper
• The Effects of Benzodiazepines on Urotensin II-Stimulated Norepinephrine Release from Rat Cerebrocortical Slices

  2009cites this paper
• Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease.

  2009cites this paper
• Human urotensin-II receptor desensitisation

  2009cites this paper
• Desensitisation of native and recombinant human urotensin-II receptors

  2009cites this paper
• Structure–activity relationship study on Tyr9 of urotensin-II(4–11): Identification of a partial agonist of the UT receptor

  2009cites this paper
• Urotensin II in cardiovascular regulation

  2008cites this paper
• The Urotensin II System in Ischaemic Myocardial Dysfunction.

  2008cites this paper
• UII / GPR 14 is involved in NF-κ B-mediated colonic inflammation in vivo and in vitro

  year unknowncites this paper